Novel Aminopropiophenones as Potential Antidepressants

Drug Development Research

Volumn 60, Issue 4, 2003, Pages 252-260

  Foley, Kevin F ^a   Cozzi, Nicholas V ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Bupropion; Depression; Locomotor; Methcathinone; Porsolt; Psychostimulant

Indexed keywords

2 (ISOPROPYLAMINO) 1 PHENYLPROPAN 1 ONE; 2 (METHYLAMINO) 1 (3 BROMOPHENYL)PROPAN 1 ONE; 2 (METHYLAMINO) 1 (4 BROMOPHENYL)PROPAN 1 ONE; 2 (TERT BUTYLAMINO) 1 PHENYLPROPAN 1 ONE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DESIPRAMINE; METHCATHINONE; PROPIOPHENONE DERIVATIVE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG STRUCTURE; LOCOMOTION; MALE; NONHUMAN; RAT; STRUCTURE ANALYSIS; SWIMMING;

EID: 0345306702     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10297     Document Type: Article

References (44)

1. Beckett AH, Shenoy EV. 1973. The effect of N-alkyl chain length of stereochemistry on the absorption, metabolism and during excretion of N-alkylamphetamines in man. J Pharm Pharmacol 25:793-799.
2. Bergman J, Madras BK, Johnson SE, Spealman RD. 1989. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
3. Borsini F, Meli A. 1988. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147-160.
4. Bruce RB, Maynard WR, Jr. 1968. Fenfluramine metabolism. J Pharm Sci 57:1173-1176.
5. Caldwell J. 1976. The metabolism of amphetamines in mammals. Drug Metab Rev 5:219-280.
6. Caldwell J, Koster U, Smith RL, Williams RT. 1975. Species variations in the N-oxidation of chlorphentermine. Biochem Pharmacol 24:2225-2232.
7. Cooper BR, Hester TJ, Maxwell RA. 1980. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215:127-134.
8. Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM. 1994. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 11:133-141.
9. Cozzi NV, Foley KF. 1999. Bromine substitution at the ring 3- or 4-position of methcathinone enhances potency at serotonin uptake transporters. Soc Neurosci Abstr 25:678.17.
10. Cozzi NV, Sievert MK, Shulgin AT, Jacob III P, Ruoho AE. 1999. Inhibition of plasma membrane monoamine transporters by b-ketoamphetamines. Eur J Pharmacol 381:63-69.
11. Dal Cason TA, Young R, Glennon RA. 1997. Cathinone: an investigation of several N-alkyl and methylenedioxy- substituted analogs. Pharmacol Biochem Behav 58:1109-1116.
12. Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L. 2001. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adol Psychiatry 40:307-314.
13. Detke MJ, Rickels M, Lucki I. 1995. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72.
14. Emerson TS, Cisek JE. 1993. Methcathinone: a Russian designer amphetamine infiltrates the rural Midwest. Ann Emerg Med 22:1897-1903.
15. Foley KF, Cozzi NV. 2002. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs. Naunyn-Schmiedeberg's Arch Pharmacol 365:457-461.
16. Glennon RA, Yousif M, Naiman N, Kalix P. 1987. Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547-551.
17. Goldstone MS. 1993. 'Cat': methcathinone: a new drug of abuse. JAMA 269:2508.
18. Gonzales DH, Nides MA, Ferry LH, Kustra RP, Jamerson BD, Segall N, Herrero LA, Krishen A, Sweeney A, Buaron K, Metz A. 2001. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 69:438-444.
19. Gorka Z, Wojtasik E. 1980. The effect of antidepressants on behavioral despair in rats. Pol J Pharmacol Pharm 32:463-468.
20. Griffith JD, Carranza J, Griffith C, Miller LL. 1983. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 44:206-208.
21. Grubbs F. 1969. Procedures for detecting outlying observations in samples. Technometrics 11:1-21.
22. James RS, Sharp WS, Bastain TM, Lee PP, Walter JM, Czarnolewski M, Castellanos FX. 2001. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adol Psychiatry 40:1268-1276.
23. Kaminskas LM, Irvine RJ, Callaghan PD, White JM, Kirkbride P. 2002. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine. Psychopharmacology (Berl) 160:155-160.
24. Kaminski BJ, Griffiths RR. 1994. Intravenous self-injection of methcathinone in the baboon. Pharmacol Biochem Behav 47: 981-983.
25. Lamb RJ, Griffiths RR. 1990. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl) 102:183-190.
26. McCormick J. 2002. Recreational bupropion abuse in a teenager. Br J Clin Pharmacol 53:214.
27. Porsolt RD. 1979. Animal model of depression. Biomedicine 30:139-140.
28. Porsolt RD, Le_Pichon M, Jalfre M. 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732.
29. Riviere GJ, Byrnes KA, Gentry WB, Owens SM. 1999. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 291:1220-1226.
30. Rosen DS. 1993. Methcathinone. J Adoles Health 14:426.
31. Shimazoe T, Shibata S, Ueki S. 1987. A new forced swimming test for the evaluation of antidepressants in rats by recording vibration of a water tank. J Pharmacobiodyn 10:639-643.
32. Shindler J, Schachter M, Brincat S, Parkes JD. 1985. Amphetamine, mazindol, and fencamfamin in narcolepsy. Br Med J (Clin Res Ed) 290:1167-1170.
33. Simpson LL. 1979. Blood pressure and heart rate responses evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine. I. The relationship between evoked responses and plasma levels of drug. J Pharmacol Exp Ther 211:225-230.
34. Simpson LL. 1980. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine. J Pharmacol Exp Ther 213:504-508.
35. Stolk JM, Rech RH. 1967. Enhanced stimulant effects of d-amphetamine on the spontaneous locomotor activity of rats treated with reserpine. J Pharmacol Exp Ther 158:140-149.
36. Sunal R, Gumusel B, Kayaalp SO. 1994. Effect of changes in swimming area on results of "behavioral despair test". Pharmacol Biochem Behav 49:891-896.
37. Taylor WA, Sulser F. 1973. Effects of amphetamine and its hydroxylated metabolites on central noradrenergic mechanisms. J Pharmacol Exp Ther 185:620-632.
38. Wallach MB, Hedley LR. 1979. The effects of antihistamines in a modified behavioral despair test. Commun Psychopharmacol 3:35-39.
39. 3H-norepinephrine in cerebral cortex of rat brain. J Pharmacol Exp Ther 189:725-732.
40. Yamada H, Shiiyama S, Soejima-Ohkuma T, Honda S, Kumagai Y, Cho AK, Oguri K, Yoshimura H. 1997. Deamination of amphetamines by cytochromes P450: studies on substrate specificity and regioselectivity with microsomes and purified CYP2C subfamily isozymes. J Toxicol Sci 22:65-73.
41. Young R, Glennon RA. 1993. Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex. Pharmacol Biochem Behav 45:229-231.
42. Zabik JE, Levine RM, Maickel RP. 1978. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity. Pharmacol Biochem Behav 8: 429-435.
43. Zarrindast MR, Hosseini-Nia T. 1988. Anorectic and behavioural effects of bupropion. Gen Pharmacol 19:201-204.
44. Zhingel KY, Dovensky W, Crossman A, Allen A. 1991. Ephedrone: 2-methylamino-1-phenylpropan-1-one (Jeff). J Forensic Sci 36:915-920.